On March 1, 2018, Bhupendra Singh, the head of the National Pharmaceutical Pricing Authority (NPPA) with a year of his tenure left, was transferred to the National Authority for Chemical Weapons Convention, sparking protests from pro-access activists. They alleged that an “industry and hospital lobby”–mainly large multinational pharmaceutical companies and corporate hospitals–was behind the transfer.
The NPPA is the government agency responsible for setting prices of drugs and ensuring drug availability. Singh had been at its helm since 2016, and under his